PLoS ONE (Jan 2023)

Evaluation of machine learning algorithms for the prognosis of breast cancer from the Surveillance, Epidemiology, and End Results database.

  • Ruiyang Wu,
  • Jing Luo,
  • Hangyu Wan,
  • Haiyan Zhang,
  • Yewei Yuan,
  • Huihua Hu,
  • Jinyan Feng,
  • Jing Wen,
  • Yan Wang,
  • Junyan Li,
  • Qi Liang,
  • Fengjiao Gan,
  • Gang Zhang

DOI
https://doi.org/10.1371/journal.pone.0280340
Journal volume & issue
Vol. 18, no. 1
p. e0280340

Abstract

Read online

IntroductionMany researchers used machine learning (ML) to predict the prognosis of breast cancer (BC) patients and noticed that the ML model had good individualized prediction performance.ObjectiveThe cohort study was intended to establish a reliable data analysis model by comparing the performance of 10 common ML algorithms and the the traditional American Joint Committee on Cancer (AJCC) stage, and used this model in Web application development to provide a good individualized prediction for others.MethodsThis study included 63145 BC patients from the Surveillance, Epidemiology, and End Results database.ResultsThrough the performance of the 10 ML algorithms and 7th AJCC stage in the optimal test set, we found that in terms of 5-year overall survival, multivariate adaptive regression splines (MARS) had the highest area under the curve (AUC) value (0.831) and F1-score (0.608), and both sensitivity (0.737) and specificity (0.772) were relatively high. Besides, MARS showed a highest AUC value (0.831, 95%confidence interval: 0.820-0.842) in comparison to the other ML algorithms and 7th AJCC stage (all P ConclusionsThe comparative study of multiple forecasting models utilizing a large data noted that MARS based model achieved a much better performance compared to other ML algorithms and 7th AJCC stage in individualized estimation of survival of BC patients, which was very likely to be the next step towards precision medicine.